Compare MSN & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSN | LEXX |
|---|---|---|
| Founded | 1948 | 2004 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2M | 8.7M |
| IPO Year | 1995 | 2011 |
| Metric | MSN | LEXX |
|---|---|---|
| Price | $0.40 | $3.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 267.6K | 82.6K |
| Earning Date | 11-13-2026 | 07-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.09 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $77,829,000.00 | $705,923.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6,915.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 52.05 |
| 52 Week Low | $0.34 | $0.35 |
| 52 Week High | $0.85 | $14.37 |
| Indicator | MSN | LEXX |
|---|---|---|
| Relative Strength Index (RSI) | 33.93 | 35.47 |
| Support Level | $0.35 | $0.57 |
| Resistance Level | $0.41 | $12.89 |
| Average True Range (ATR) | 0.03 | 0.51 |
| MACD | -0.01 | -0.12 |
| Stochastic Oscillator | 3.65 | 25.92 |
Emerson Radio Corp designs, sources, imports, markets, sells and licenses to certain licensees a variety of houseware and consumer electronic products, both domestically and internationally, under the Emerson brand name. The Company's core business consists of selling, distributing, and licensing various low and moderately priced houseware and consumer electronic products in various categories. Its products are Houseware Products consist Microwave Ovens, Compact Refrigerators, Toaster Ovens, Heaters and Fans; Audio Products consist Clock Radios, Bluetooth Speakers, Karaoke Machines, Wireless Charging; and Other consist Televisions, Security Products, Massagers. It operates in One segment. Majority of revenue comes from United States.
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.